Form 4 for GILD Gilead Sciences
Accepted 2026-02-05 00:00:00 ET · period of report 2026-02-03 · accession 0001310204-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-05 | 2026-02-03 | GILD | Dickinson Andrew D | CFO | A - Grant | $0.00 | +44.9K | 195.4K | +30% | $0 | |
| 2026-02-05 | 2026-02-03 | GILD | Dickinson Andrew D | CFO | F - Tax | $143.28 | -24.8K | 170.6K | -13% | -$3.55M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-03 | A | A | 44,867 | $0.00 | 195,370 | D | — | — | (F1) Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met. |
| 2 | Common | Common Stock | 2026-02-03 | F | D | 24,802 | $143.28 | 170,568 | D | — | — |